ArticleNature medicine2021
A dangerous measles future looms beyond the COVID-19 pandemic.
Article in Nature medicine, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 47 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
47 citing papers in PubMed.
- Serological Susceptibility to Measles Among International Students in South Korea After a Cluster of Cases: A Cross-Sectional Study.Tropical medicine and infectious disease · 2026Article
- Integrating explainable AI and One Health: a new frontier in combating infectious diseases.EBioMedicine · 2026Review
- Co-infections and Reactivation of some Herpesviruses (HHV) and Measles Virus (MeV) in Egyptian Cancer Patients infected with Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2).Journal of the Egyptian National Cancer Institute · 2025Observational
- Seroprevalence against measles, Austria, stratified by birth years 1922 to 2024.Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin · 2025Article
- Socio-demographic factors affecting the first and second dose of measles vaccination status among under-five children: Perspectives from South Asian countries.Preventive medicine reports · 2024Article
- Optimal Timing Regularly Outperforms Higher Coverage in Preventative Measles Supplementary Immunization Campaigns.Vaccines · 2024Article
- Article
- Accelerating Global Measles and Rubella Eradication-Saving Millions of Lives, Preventing Disability, and Averting the Next Pandemic.Vaccines · 2024Article
- Assessment of using Google Trends for real-time monitoring of infectious disease outbreaks: a measles case study.Scientific reports · 2024Article
- Measuring what matters: Context-specific indicators for assessing immunisation performance in Pacific Island Countries and Areas.PLOS global public health · 2024Article
- Sustaining measles and rubella elimination through the Regional Monitoring and Re-Verification Commission in the Americas.Revista panamericana de salud publica = Pan American journal of public health · 2024Article
- Pacific Island Countries demonstrate the sustained success of a coordinated measles mass vaccination campaign.The Lancet regional health. Western Pacific · 2024Article
- A phase II/III randomised, comparative study evaluating the safety and immunogenicity of Biological E's live, attenuated Measles-Rubella vaccine in 9-12 month old healthy infants.Contemporary clinical trials communications · 2023Article
- Suppression of viral RNA polymerase activity is necessary for persistent infection during the transformation of measles virus into SSPE virus.PLoS pathogens · 2023Article
- Article
- Mitigating Vaccine Hesitancy and Building Trust to Prevent Future Measles Outbreaks in England.Vaccines · 2023Article
- Article
- China has the momentum to eliminate measles.The Lancet regional health. Western Pacific · 2023Article
- Evolving measles status and immunization policy development in six European countries.Human vaccines & immunotherapeutics · 2022Review
- Assessing the Effects of Measles Virus Infections on Childhood Infectious Disease Mortality in Brazil.The Journal of infectious diseases · 2022Article
Corrections and comments
- Commented on by
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
PubMed holds no abstract for this paper.
Indexed as
Identifiers
33589823What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.